Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26354
Title: Host IL-11 signaling suppresses CD4+ T cell-mediated anti-tumor responses to colon cancer in mice.
Austin Authors: Huynh, Jennifer;Baloyan, David;Chisanga, David;Shi, Wei;O'Brien, Megan;Afshar-Sterle, Shoukat ;Alorro, Mariah;Pang, Lokman;Williams, David S ;Parslow, Adam C;Thilakasiri, Pathum;Eissmann, Moritz F ;Boon, Louis;Masson, Frederick;Chand, Ashwini L ;Ernst, Matthias 
Affiliation: Olivia Newton-John Cancer Research Institute
School of Cancer Medicine at La Trobe University
Olivia Newton-John Cancer Wellness and Research Centre
Anatomical Pathology
Bioceros, CM Utrecht
University of Toulouse, CNRS, INSERM, UPS
Issue Date: 27-Apr-2021
Date: 2021-04-27
Publication information: Cancer immunology research 2021; 9(7): 735-747
Abstract: Interleukin-11 (IL-11) is a member of the IL-6 family of cytokines and signals through its cognate receptor subunits, IL11RA and glycoprotein 130 (GP130) to elicit biological responses via the JAK/STAT signaling pathway. IL-11 contributes to cancer progression by promoting the survival and proliferation of cancer cells, but the potential immunomodulatory properties of IL-11 signaling during tumor development have thus far remained unexplored. Here, we have characterized a role for IL-11 in regulating CD4+ T cell-mediated anti-tumor responses. Absence of IL-11 signaling impaired tumor growth in a sporadic mouse model of colon cancer and syngeneic allograft models of colon cancer. Adoptive bone marrow transfer experiments and in vivo depletion studies demonstrated that the tumor-promoting activity of IL-11 was mediated through its suppressive effect on host CD4+ T cells in the tumor microenvironment. Indeed, when compared to Il11ra-proficient CD4+ T cells associated with MC38 tumors, their Il11ra-deficient counterparts displayed elevated expression of mRNA encoding the anti-tumor mediators IFNγ and TNFα. Likewise, IL-11 potently suppressed the production of pro-inflammatory cytokines (IFNγ, TNFα, IL-6, and IL12p70) by CD4+ T cells in vitro, which we corroborated by RNAscope analysis of human colorectal cancers, where IL11RAhigh tumors showed less IFNG and CD4 expression than IL11RAlow tumors. Therefore, our results ascribe for a tumor-cell extrinsic immunomodulatory role for IL-11 during tumor development that is amenable to anti-cytokine based clinical management of colon cancer.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26354
DOI: 10.1158/2326-6066.CIR-19-1023
ORCID: 0000-0002-0421-3957
0000-0002-9868-6914
0000-0001-8673-1290
0000-0002-2855-0616
0000-0002-1245-729X
Journal: Cancer Immunology Research
PubMed URL: 33906864
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

48
checked on Nov 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.